Prof Harry Crijns (Maastricht University Medical Center, Maastricht, NL) discusses the 'Wait-and-See versus Acute Cardioversion trial in Recent-Onset AF patients' with his colleagues Dr Elton Dudink and Dr Nikki Pluymaekers who conducted the trial.

Filmed on site at EHRA 2019 by Radcliffe Cardiology

Questions:

1. What is the rationale for this study?

2. What was the design of the trial?

3. What was the endpoint of the study and why?

4. Was the wait-and-see approach effective?

5. Did you see any complications?

6. Was the wait-and-see approach safe?

7. Was the wait-and-see approach cost-effective?

8. What are the implications for clinical practice?

9. Are further studies planned?

Videographer: Tom Green/Mike Knight
Education Lead: Dr Harry Crijns